<- Go Home
Nanosonics Limited
Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Market Cap
AUD 1.2B
Volume
1.0M
Cash and Equivalents
AUD 144.5M
EBITDA
AUD 17.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
AUD 142.4M
Profit Margin
77.42%
52 Week High
AUD 5.18
52 Week Low
AUD 2.67
Dividend
N/A
Price / Book Value
6.26
Price / Earnings
72.57
Price / Tangible Book Value
6.26
Enterprise Value
AUD 1.0B
Enterprise Value / EBITDA
51.30
Operating Income
AUD 12.5M
Return on Equity
9.09%
Return on Assets
3.25
Cash and Short Term Investments
AUD 144.5M
Debt
AUD 9.2M
Equity
AUD 189.0M
Revenue
AUD 184.0M
Unlevered FCF
AUD 25.5M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium